Christopher J. Kirk
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome(2007)669 cited
- → A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis(2009)590 cited
- → The stimulation of inositol lipid metabolism that accompanies calcium mobilization in stimulated cells: defined characteristics and unanswered questions(1981)517 cited
- → Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor Specificity(2012)491 cited
- → Hormonal Stimulation of Phosphatidylinositol Breakdown, with Particular Reference to the Hepatic Effects of Vasopressin(1979)435 cited
- → Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events(2011)405 cited